Join Our Symposium Organized by eLife: Exploring the Impact of COVID-19 on Cancer Outcomes
Mar 25
In the realm of healthcare, the COVID-19 pandemic has brought unprecedented challenges, particularly in the field of cancer care. As we navigate these complexities, it becomes essential to assess the repercussions of the pandemic on cancer outcomes and explore strategies to mitigate its effects.
We are thrilled to announce an upcoming symposium organized by eLife, one of the leading biomedical journals, titled "The Impact of the COVID-19 Pandemic on Cancer Outcomes." This symposium serves as a vital forum for experts, researchers, and stakeholders to convene and delve into the evolving landscape of cancer care in the context of the pandemic.
Event Details:
Date: Wednesday, April 17 at 3pm BST | 10am EDT | 2pm UTC
Location: Zoom
Registration: https://elifesciences.org/events/eabde7fd/symposium-the-impact-of-the-covid-19-pandemic-on-cancer-outcomes
The symposium will be chaired by eLife Editors, Diane Harper, University of Michigan, United States, and Eduardo Franco, McGill University, Canada. Esteemed scientists from the International Agency for Research on Cancer (IARC/WHO), The Danish Clinical Quality Program – National Clinical Registries (RKKP), and the Division of Cancer Epidemiology, McGill University, will be presenting different perspectives on cancer care during Covid-19 pandemic.
More information on different talks that will be delivered during the symposium can be found here.
Epistudia's Contribution:
Our CEO, Dr. Taulant Muka, will be representing Epistudia and providing a talk on “Navigating the COVID-19 Crisis: The Effects on Cancer Prevention, Management, and Patient Care.” Dr. Muka will present research findings from our recent umbrella review on cancer care during the pandemic, aiming to foster a deeper understanding of the challenges faced that patients, clinicians, and researchers in the oncology community faced during the Covid-19 pandemic.
This symposium presents a unique opportunity for stakeholders across the healthcare spectrum to come together, exchange insights, and collaboratively work towards enhancing cancer care in the era of COVID-19. Researchers, clinicians, policymakers, and advocates are encouraged to join the conversation and contribute to shaping the future of oncology.
Register now to secure your spot and be part of the dialogue on the intersection of COVID-19 and cancer outcomes.
We are thrilled to announce an upcoming symposium organized by eLife, one of the leading biomedical journals, titled "The Impact of the COVID-19 Pandemic on Cancer Outcomes." This symposium serves as a vital forum for experts, researchers, and stakeholders to convene and delve into the evolving landscape of cancer care in the context of the pandemic.
Event Details:
Date: Wednesday, April 17 at 3pm BST | 10am EDT | 2pm UTC
Location: Zoom
Registration: https://elifesciences.org/events/eabde7fd/symposium-the-impact-of-the-covid-19-pandemic-on-cancer-outcomes
The symposium will be chaired by eLife Editors, Diane Harper, University of Michigan, United States, and Eduardo Franco, McGill University, Canada. Esteemed scientists from the International Agency for Research on Cancer (IARC/WHO), The Danish Clinical Quality Program – National Clinical Registries (RKKP), and the Division of Cancer Epidemiology, McGill University, will be presenting different perspectives on cancer care during Covid-19 pandemic.
More information on different talks that will be delivered during the symposium can be found here.
Epistudia's Contribution:
Our CEO, Dr. Taulant Muka, will be representing Epistudia and providing a talk on “Navigating the COVID-19 Crisis: The Effects on Cancer Prevention, Management, and Patient Care.” Dr. Muka will present research findings from our recent umbrella review on cancer care during the pandemic, aiming to foster a deeper understanding of the challenges faced that patients, clinicians, and researchers in the oncology community faced during the Covid-19 pandemic.
This symposium presents a unique opportunity for stakeholders across the healthcare spectrum to come together, exchange insights, and collaboratively work towards enhancing cancer care in the era of COVID-19. Researchers, clinicians, policymakers, and advocates are encouraged to join the conversation and contribute to shaping the future of oncology.
Register now to secure your spot and be part of the dialogue on the intersection of COVID-19 and cancer outcomes.
30% discount offer!
Click the button to make this offer yours! Limited-time only!